Related Experiment Videos

Activities of liver cell-producing coagulation factors in thalassemic children

D Romcai1, T Tositarat, P Kulapongs

  • 1Department of Clinical Microscopy, Chiang Mai University, Thailand.

Birth Defects Original Article Series
|January 1, 1988
PubMed

Insights

Beta-thalassemia children show depressed levels of key clotting factors, indicating liver dysfunction. These coagulation abnormalities are linked to hepatic parenchymal cell involvement in beta-thalassemia.

Area of Science:

  • Hematology
  • Pediatric Medicine
  • Clinical Biochemistry

Background:

  • Beta-thalassemia is a genetic blood disorder.
  • Coagulation factor deficiencies can occur in various chronic diseases.
  • Liver function is crucial for synthesizing coagulation factors.

Purpose of the Study:

  • To investigate coagulation profiles in children with beta-thalassemia.
  • To assess the impact of splenectomy and vitamin K on coagulation.
  • To explore the role of liver involvement in beta-thalassemia-related coagulation abnormalities.

Main Methods:

  • Coagulation studies were performed on 20 children with beta-thalassemia and 16 controls.
  • Factor activities including the prothrombin complex (II, VII, IX, X), V, I, and VIII were measured.
  • Comparisons were made between splenectomized and non-splenectomized groups, and with/without vitamin K administration.

Main Results:

  • Uniform depression in hepatic-synthesized factors (II, VII, IX, X, V, I) was observed in beta-thalassemia patients.
  • Factor VIII activity remained normal.
  • No significant differences in prothrombin complex activity were found based on splenectomy status or vitamin K use.
  • Absence of factor VII cold-activation in thalassemia plasma suggests impaired liver function.

Conclusions:

  • Beta-thalassemia is associated with impaired synthesis of hepatic coagulation factors, indicating liver involvement.
  • Splenectomy and vitamin K administration did not significantly alter prothrombin complex activity.
  • Further investigation into plasma kallikrein and HMW kininogen may elucidate the mechanisms of factor VII abnormalities.

Related Concept Videos